# Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

> clinical trial · VERIFIED · 2026-07-01

Status: NOT_YET_RECRUITING · Sponsor: University of Alabama at Birmingham · Condition: Idiopathic Pulmonary Fibrosis

- Company: University of Alabama at Birmingham
- Sector: pulmonology
- Primary source: https://clinicaltrials.gov/study/NCT07674745

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.